Liquidia Technologies, Inc. (LQDA): Price and Financial Metrics
GET POWR RATINGS... FREE!
LQDA POWR Grades
- LQDA scores best on the Sentiment dimension, with a Sentiment rank ahead of 66.22% of US stocks.
- The strongest trend for LQDA is in Growth, which has been heading up over the past 177 days.
- LQDA's current lowest rank is in the Stability metric (where it is better than 21.63% of US stocks).
LQDA Stock Summary
- The capital turnover (annual revenue relative to shareholder's equity) for LQDA is 0.15 -- better than merely 14.79% of US stocks.
- LQDA's price/sales ratio is 32.27; that's higher than the P/S ratio of 95.35% of US stocks.
- With a year-over-year growth in debt of 51.26%, LIQUIDIA CORP's debt growth rate surpasses 80.7% of about US stocks.
- If you're looking for stocks that are quantitatively similar to LIQUIDIA CORP, a group of peers worth examining would be KIND, RAMP, SUMO, LIDR, and ASAN.
- LQDA's SEC filings can be seen here. And to visit LIQUIDIA CORP's official web site, go to www.liquidia.com.
LQDA Valuation Summary
- LQDA's price/sales ratio is 29.4; this is 1300% higher than that of the median Healthcare stock.
- Over the past 55 months, LQDA's price/earnings ratio has gone down 3.
Below are key valuation metrics over time for LQDA.
| Stock | Date | P/S | P/B | P/E | EV/EBIT |
|---|---|---|---|---|---|
| LQDA | 2023-01-30 | 29.4 | 4.3 | -8.8 | -7.5 |
| LQDA | 2023-01-27 | 31.2 | 4.5 | -9.4 | -8.1 |
| LQDA | 2023-01-26 | 31.6 | 4.6 | -9.5 | -8.2 |
| LQDA | 2023-01-25 | 32.5 | 4.7 | -9.7 | -8.5 |
| LQDA | 2023-01-24 | 32.3 | 4.7 | -9.7 | -8.4 |
| LQDA | 2023-01-23 | 30.3 | 4.4 | -9.1 | -7.8 |
LQDA's Quality Factors
The “Quality” component of the POWR Ratings focuses on 31 different factors of a companies fundamentals and operational strength. Here are some key insights as we drill into the specifics of these quality attributes.- LQDA has a Quality Grade of D, ranking ahead of 6.72% of graded US stocks.
- LQDA's asset turnover comes in at 0.106 -- ranking 153rd of 186 Medical Equipment stocks.
- 500 - Internal server error
The table below shows LQDA's key quality metrics over time.
| Period | Asset Turnover | Gross Margin | ROIC |
|---|---|---|---|
| 2021-09-30 | 0.106 | 0.756 | -1.103 |
| 2021-06-30 | 0.075 | 0.771 | -1.558 |
| 2021-03-31 | 0.049 | 0.756 | -2.131 |
| 2020-12-31 | 0.011 | 0.679 | -2.776 |
| 2020-09-30 | 0.000 | NA | -3.022 |
| 2020-06-30 | 0.000 | NA | -2.692 |
LQDA Price Target
For more insight on analysts targets of LQDA, see our LQDA price target page. And for a list of of all stocks sorted by upside potential based on analyst target price, see our Top Price Target page.
| Average Price Target | $4.25 | Average Broker Recommendation | 1.5 (Moderate Buy) |
LQDA Stock Price Chart Interactive Chart >
LQDA Price/Volume Stats
| Current price | $6.85 | 52-week high | $8.79 |
| Prev. close | $6.90 | 52-week low | $3.26 |
| Day low | $6.69 | Volume | 231,758 |
| Day high | $6.97 | Avg. volume | 535,976 |
| 50-day MA | $6.13 | Dividend yield | N/A |
| 200-day MA | $5.46 | Market Cap | 441.79M |
Liquidia Technologies, Inc. (LQDA) Company Bio
Liquidia Technologies, Inc., a late-stage clinical biopharmaceutical company, focuses on the development and commercialization of human therapeutics. Its lead product candidate, LIQ861, an inhaled dry powder formulation of treprostinil that is in Phase III clinical trials used for the treatment of pulmonary arterial hypertension. The company is also developing LIQ865, which completed Phase Ib clinical trials for the treatment of local post-operative pain. The company was founded in 2004 and is based in Morrisville, North Carolina.
Latest LQDA News From Around the Web
Below are the latest news stories about LIQUIDIA CORP that investors may wish to consider to help them evaluate LQDA as an investment opportunity.
Decision moves Liquidia, United Therapeutics patent dispute toward resolutionA patent dispute between Liquidia and United Therapeutics is potentially nearing a resolution after a recent decision by a federal patent board. |
LQDA (Liquidia Corporation) has powerful resultsAs of Thursday, Liquidia Corporation’s (NASDAQ:LQDA) stock closed at $7.01, up from $6.39 the previous day. While Liquidia Corporation has overperformed by 9.70%, investors are advised to look at stock chart patterns for technical insight. Within its last year performance, LQDA rose by 16.83%, with highs and lows ranging from $8.79 to $3.26, whereas the […] |
Strength Seen in Liquidia Technologies, Inc. (LQDA): Can Its 9.7% Jump Turn into More Strength?Liquidia Technologies, Inc. (LQDA) saw its shares surge in the last session with trading volume being higher than average. The latest trend in earnings estimate revisions may not translate into further price increase in the near term. |
Patent Trial and Appeal Board (PTAB) Reaffirms Decision to Invalidate All Claims of United Therapeutics (UTHR) Patent No. 10,716,793 (‘793 Patent)PTAB rejects UTHR’s request for rehearing of its decision in the inter partes review of the ‘793 Patent (‘793 IPR)PTAB clarified grounds upon which it based its finding that the cited publications, which invalidated the claims, constituted prior artCompany reaffirms expectation of legal resolution in late 2023 or the first half of 2024 MORRISVILLE, N.C., Feb. 02, 2023 (GLOBE NEWSWIRE) -- Liquidia Corporation (NASDAQ: LQDA) (Liquidia or the Company) announced that the PTAB has reaffirmed its orig |
Liquidia Corporation Reports Inducement Grants under Nasdaq Listing Rule 5635(c)(4)MORRISVILLE, N.C., Feb. 02, 2023 (GLOBE NEWSWIRE) -- Liquidia Corporation (NASDAQ: LQDA) today announced the grant of inducement stock options exercisable for an aggregate of 10,000 shares of Liquidia’s common stock to newly hired non-executive employees under the Liquidia Corporation 2022 Inducement Plan (the “Inducement Plan”). Each stock option was granted as an inducement material to the grantee’s acceptance of employment with Liquidia (or one of its subsidiaries) as a component of the grant |
LQDA Price Returns
| 1-mo | 19.76% |
| 3-mo | 37.55% |
| 6-mo | 19.96% |
| 1-year | 6.04% |
| 3-year | 13.41% |
| 5-year | N/A |
| YTD | 7.54% |
| 2022 | 30.80% |
| 2021 | 65.08% |
| 2020 | -30.99% |
| 2019 | -80.26% |
| 2018 | N/A |
Continue Researching LQDA
Want to see what other sources are saying about Liquidia Technologies Inc's financials and stock price? Try the links below:Liquidia Technologies Inc (LQDA) Stock Price | Nasdaq
Liquidia Technologies Inc (LQDA) Stock Quote, History and News - Yahoo Finance
Liquidia Technologies Inc (LQDA) Stock Price and Basic Information | MarketWatch
Loading social stream, please wait...